Investors didn’t seem pleased with a solid earnings and revenue beat from CVS Health, with shares in the healthcare company heading lower on Wednesday after the company slashed its full-year guidance for the third consecutive quarter.
CVS reported earnings of $2.21 a share on revenue of $89.8 billion, firmly topping expectations among analysts surveyed by FactSet of earnings of $2.13 a share on revenue of $88.3 billion. But CVS lowered its guidance range for diluted earnings per share measured under U.S. Generally Accepted Accounting Principles. The company said it now sees earnings by this metric in a range of $6.37 to $6.61 a share. CVS said in February that earnings could be $7.73 to $7.93 a share in 2023 but has revised this range lower in both May and August.Write to Jack Denton at [email protected]
المملكة العربية السعودية أحدث الأخبار, المملكة العربية السعودية عناوين
Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.
Arista Stock Jumps as Earnings Top EstimatesInvestors had worried about the outlook after Meta Platforms issued a more conservative capital-spending forecast than expected.
اقرأ أكثر »
CVS Health’s stock up after earnings beat, but company lowers full-year EPS guidanceCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
اقرأ أكثر »
Fresh Del Monte’s stock slides premarket after earnings fall short of estimatesCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
اقرأ أكثر »
AGCO Stock Is Rising. Earnings Crushed Estimates.Farm-equipment maker AGCO saw 'robust demand' as third-quarter numbers beat estimates. It also raised guidance.
اقرأ أكثر »